199 related articles for article (PubMed ID: 38017231)
1. Enhancing Anticancer Efficacy of Formononetin Microspheres via Microfluidic Fabrication.
Cao X; Li Q; Li X; Liu Q; Liu K; Deng T; Weng X; Yu Q; Deng W; Yu J; Wang Q; Xiao G; Xu X
AAPS PharmSciTech; 2023 Nov; 24(8):241. PubMed ID: 38017231
[TBL] [Abstract][Full Text] [Related]
2. Three months extended-release microspheres prepared by multi-microchannel microfluidics in beagle dog models.
Kim JH; Ryu CH; Chon CH; Kim S; Lee S; Maharjan R; Kim NA; Jeong SH
Int J Pharm; 2021 Oct; 608():121039. PubMed ID: 34450228
[TBL] [Abstract][Full Text] [Related]
3. Optimization of O/W Emulsion Solvent Evaporation Method for Itraconazole Sustained Release Microspheres.
Wang W; Kojima H; Gao M; Yin X; Uchida T; Ni J
Chem Pharm Bull (Tokyo); 2023; 71(7):520-527. PubMed ID: 37394601
[TBL] [Abstract][Full Text] [Related]
4. Inhalable functional mixed-polymer microspheres to enhance doxorubicin release behavior for lung cancer treatment.
Li W; Chen S; Zhang L; Zhang Y; Yang X; Xie B; Guo J; He Y; Wang C
Colloids Surf B Biointerfaces; 2020 Dec; 196():111350. PubMed ID: 32911292
[TBL] [Abstract][Full Text] [Related]
5. PLGA sustained-release microspheres loaded with an insoluble small-molecule drug: microfluidic-based preparation, optimization, characterization, and evaluation
Su Y; Liu J; Tan S; Liu W; Wang R; Chen C
Drug Deliv; 2022 Dec; 29(1):1437-1446. PubMed ID: 35532150
[TBL] [Abstract][Full Text] [Related]
6. Long-acting injectable donepezil microspheres: Formulation development and evaluation.
Choi GW; Lee S; Kang DW; Kim JH; Kim JH; Cho HY
J Control Release; 2021 Dec; 340():72-86. PubMed ID: 34715262
[TBL] [Abstract][Full Text] [Related]
7. The recent insight in the release of anticancer drug loaded into PLGA microspheres.
Rahmani F; Naderpour S; Nejad BG; Rahimzadegan M; Ebrahimi ZN; Kamali H; Nosrati R
Med Oncol; 2023 Jul; 40(8):229. PubMed ID: 37410278
[TBL] [Abstract][Full Text] [Related]
8. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
Blanco D; Alonso MJ
Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
[TBL] [Abstract][Full Text] [Related]
9. Aqueous remote loading of setmelanotide in poly(lactic-co-glycolic acid) microspheres for long-term obesity treatment.
Wang S; Downing G; Olsen KF; Sawyer TK; Cone RD; Schwendeman SP
J Control Release; 2023 Dec; 364():589-600. PubMed ID: 37678438
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of a model nucleoside (guanosine) release from biodegradable poly(DL-lactide-co-glycolide) microspheres: a delivery system for long-term intraocular delivery.
Chowdhury DK; Mitra AK
Pharm Dev Technol; 2000; 5(2):279-85. PubMed ID: 10810757
[TBL] [Abstract][Full Text] [Related]
11. Preparation of uniform-sized GeXIVA[1,2]-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency.
Li L; Li Z; Guo Y; Zhang K; Mi W; Liu J
Drug Deliv; 2022 Dec; 29(1):2283-2295. PubMed ID: 35866254
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
Woo BH; Jiang G; Jo YW; DeLuca PP
Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769
[TBL] [Abstract][Full Text] [Related]
13. Microencapsulation of luteinizing hormone-releasing hormone agonist in poly (lactic-co-glycolic acid) microspheres by spray-drying.
Shi NQ; Zhou J; Walker J; Li L; Hong JKY; Olsen KF; Tang J; Ackermann R; Wang Y; Qin B; Schwendeman A; Schwendeman SP
J Control Release; 2020 May; 321():756-772. PubMed ID: 31935481
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, taxol.
Wang YM; Sato H; Adachi I; Horikoshi I
Chem Pharm Bull (Tokyo); 1996 Oct; 44(10):1935-40. PubMed ID: 8904823
[TBL] [Abstract][Full Text] [Related]
15. PLGA and PHBV microsphere formulations and solid-state characterization: possible implications for local delivery of fusidic acid for the treatment and prevention of orthopaedic infections.
Yang C; Plackett D; Needham D; Burt HM
Pharm Res; 2009 Jul; 26(7):1644-56. PubMed ID: 19384471
[TBL] [Abstract][Full Text] [Related]
16. Preparation of uniform-sized exenatide-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency and bio-stability.
Qi F; Wu J; Fan Q; He F; Tian G; Yang T; Ma G; Su Z
Colloids Surf B Biointerfaces; 2013 Dec; 112():492-8. PubMed ID: 24075786
[TBL] [Abstract][Full Text] [Related]
17. Microfluidic-based fabrication and characterization of drug-loaded PLGA magnetic microspheres with tunable shell thickness.
He C; Zeng W; Su Y; Sun R; Xiao Y; Zhang B; Liu W; Wang R; Zhang X; Chen C
Drug Deliv; 2021 Dec; 28(1):692-699. PubMed ID: 33818236
[TBL] [Abstract][Full Text] [Related]
18. Formulation Optimization and In Vitro Characterization of Granisetronloaded Polylactic-co-glycolic Acid Microspheres Prepared by a Dropping-in-liquid Emulsification Technique.
Ahmed AMQ; Chen LQ; Du HH; Sun W; Cao QR
Curr Drug Deliv; 2022; 19(6):721-729. PubMed ID: 34325634
[TBL] [Abstract][Full Text] [Related]
19. Effects of alginate coated on PLGA microspheres for delivery tetracycline hydrochloride to periodontal pockets.
Liu DZ; Chen WP; Lee CP; Wu SL; Wang YC; Chung TW
J Microencapsul; 2004 Sep; 21(6):643-52. PubMed ID: 15762321
[TBL] [Abstract][Full Text] [Related]
20. PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release.
Mallardé D; Boutignon F; Moine F; Barré E; David S; Touchet H; Ferruti P; Deghenghi R
Int J Pharm; 2003 Aug; 261(1-2):69-80. PubMed ID: 12878396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
